Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

The Dawn of Precision Medicine in Neurodegenerative Diseases

We are on the precipice of Precision Medicine in neurodegenerative diseases (NDDs)

Special thanks to Efe Alyanak, Thomas Angiulo, Puja Ghelani, Alli Gitnik, Hayden Kickbush, Jeff Stoll, Jack Verity

We are on the precipice of precision medicine in neurodegenerative diseases (NDDs) but many key questions remain:

  • What can be learned from cutting edge approaches in oncology to drive better patient outcomes in NDDs?
  • Why have NDDs remained untreatable for so long and what can be done in in the future?
  • Are we thinking about the causes of NDDs in the right way or do we need to take a step back?
  • Is the amyloid approach the panacea for all patients?
  • What will it take to diagnose the disease early?
  • How does the patient journey need to evolve for a precision medicine future in NDD?

Dive into our thinking:

The precision medicine future in neurodegenerative diseases

Download PDF

Key takeaways


Historically, NDDs have been thought of as neurological diseases, but thinking needs to evolve to capture the systemic nature and to drive future treatment in NDDs


Pharmaceutical and biotech companies should think beyond traditional approaches of just amyloid and tau, and consider other driver pathologies such as metabolic dysfunction, mental health, and inflammation


To enable timely identification, diagnosis, and monitoring, diagnostic and biopharma companies should work together to evolve and innovate diagnostics tools beyond CSF-based testing and imaging


Treatments of the future should incorporate multi-modal, personalized approach

The KPMG Precision Medicine practice is a leader in innovation across all therapeutic areas, in markets around the world. Our comprehensive offerings range from strategic front-end ideation and planning, to commercial, financial, and operational due diligence, and continuing through integration and separation. Our approach is fueled by proprietary clinical and lab data which is unparalleled in the market. Click to see more examples of the transformative work we are doing in strategydeals and operations for all stakeholders in the Precision Medicine ecosystem.

Explore more

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.